Is Neurogene Inc. overvalued?

Neurogene Inc. (NGNE) — key valuation metrics and fundamentals.

No verdict

Price

$23.93

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$378.1M

Dividend yield

0.0%

Return on equity

-44.4%

Sector

Healthcare

Fair value compares NGNE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks